Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.
暂无分享,去创建一个
L. Mandell | T. Marrie | A. Chow | R. Grossman | R. Hyland | R. Hyland | R. Grossman
[1] Malbea A Lapete,et al. Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .
[2] L. Mandell,et al. Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. , 2000, Canadian respiratory journal.
[3] T. Marrie,et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. , 2000, JAMA.
[4] M. Niederman,et al. Does appropriate antibiotic treatment influence outcome in community-acquired pneumonia (CAP)? , 2000 .
[5] L. Kozak,et al. National hospital discharge survey: annual summary, 1997. , 1999, Vital and health statistics. Series 13, Data from the National Health Survey.
[6] Sheldon P Stone,et al. Community-acquired pneumonia , 1998, The Lancet.
[7] B. Naughton,et al. Validation and Application of the Pneumonia Prognosis Index to Nursing Home Residents with Pneumonia , 1998, Journal of the American Geriatrics Society.
[8] R. Muder. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. , 1998, The American journal of medicine.
[9] M. Fine,et al. Assessing prognosis and selecting an initial site of care for adults with community-acquired pneumonia. , 1998, Infectious disease clinics of North America.
[10] I. Suramo,et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] A. Didier,et al. Guidelines for management of adult community-acquired lower respiratory tract infections , 1998 .
[12] M. R. Jacobs,et al. Determination of Activities of Levofloxacin, Alone and Combined with Gentamicin, Ceftazidime, Cefpirome, and Meropenem, against 124 Strains of Pseudomonas aeruginosa by Checkerboard and Time-Kill Methodology , 1998, Antimicrobial Agents and Chemotherapy.
[13] J. Bartlett,et al. GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA Community-Acquired Pneumonia in Adults: Guidelines for Management , 1998 .
[14] ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. , 1998, European Respiratory Journal.
[15] M. Fine,et al. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. , 1997, JAMA.
[16] M. Kolczak,et al. Incidence of Community-Acquired Pneumonia Requiring Hospitalization Results of a Population-Based Active Surveillance Study in Ohio , 1997 .
[17] M. Fine,et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.
[18] M. Fine,et al. The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study. , 1997, Archives of internal medicine.
[19] M. Fine,et al. The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. , 1997, Archives of internal medicine.
[20] A. Porath,et al. The epidemiology of community-acquired pneumonia among hospitalized adults. , 1997, The Journal of infection.
[21] J. P. Davis,et al. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[22] R. Peeling,et al. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] R. Peeling,et al. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. , 1996, The American journal of medicine.
[24] J. Serra,et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. , 1996, American journal of respiratory and critical care medicine.
[25] R. H. Gates,et al. Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis. , 1996, The Western journal of medicine.
[26] J. Bopp,et al. Blood cultures in adult patients released from an urban emergency department: a 15-month experience. , 1996, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[27] J. Bartlett. Assessment of response to antimicrobial therapy and time to discharge in patients hospitalized with community-acquired pneumonia , 1996 .
[28] J. Bartlett,et al. Clinical pathways in an acute care setting: Community-acquired pneumonia , 1996 .
[29] J. Ramirez,et al. Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. , 1996, Diagnostic microbiology and infectious disease.
[30] J. Bartlett,et al. Community‐Acquired Pneumonia: Impact of Immune Status , 1996, American journal of respiratory and critical care medicine.
[31] M. Leinonen,et al. The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. , 1995, The Journal of infectious diseases.
[32] R. van Furth,et al. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. , 1995, Thorax.
[33] S. Chevret,et al. Severe Community-acquired Pneumococcal Pneumonia , 1995 .
[34] P. Mäkelä,et al. Risk factors for pneumonia in the elderly. , 1994, The American journal of medicine.
[35] Victor L. Yu,et al. Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial Therapy , 1993 .
[36] T. Marrie,et al. Serological investigation of pneumonia as it presents to the physician's office. , 1993, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.
[37] R. Breiman,et al. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. , 1993, JAMA.
[38] S. L. Phillips,et al. The Use of Intramuscular Cefoperazone versus Intramuscular Ceftriaxone in Patients with Nursing Home‐Acquired Pneumonia , 1993, Journal of the American Geriatrics Society.
[39] S. Sahn. Management of complicated parapneumonic effusions. , 1993, The American review of respiratory disease.
[40] E. Jacobs. Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] J. Rello,et al. A three-year study of severe community-acquired pneumonia with emphasis on outcome. , 1993, Chest.
[42] L. Mandell,et al. Antimicrobial treatment of community acquired pneumonia in adults: A conference report. , 1993, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.
[43] Thebritishthoracicsocietyrese,et al. The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service. , 1992, Respiratory medicine.
[44] J. Bates,et al. Microbial etiology of acute pneumonia in hospitalized patients. , 1992, Chest.
[45] R. Adair,et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. , 1991, The New England journal of medicine.
[46] T. Speroff,et al. Comparison of physician judgment and decision aids for ordering chest radiographs for pneumonia in outpatients. , 1991, Annals of emergency medicine.
[47] I. Williams,et al. The value of routine microbial investigation in community-acquired pneumonia. , 1991, Respiratory medicine.
[48] B. Andersson,et al. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. , 1991, The Journal of infectious diseases.
[49] W. Kapoor,et al. New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases , 1990, Medicine.
[50] J. A. Cuello,et al. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. , 1990, The American review of respiratory disease.
[51] A. Ortqvist,et al. Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia. , 1990, Chest.
[52] D. Kaiser,et al. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. , 1989, Thorax.
[53] A. Chow,et al. Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations , 1989, Antimicrobial Agents and Chemotherapy.
[54] T. Marrie,et al. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.
[55] W. F. Watkins. Community acquired pneumonia: Importance of initial noninvasive bacteriologic and radiographic investigations , 1988 .
[56] M. A. Spiteri,et al. RELIABILITY OF ELICITING PHYSICAL SIGNS IN EXAMINATION OF THE CHEST , 1988, The Lancet.
[57] T. Koepsell,et al. Risk factors for acquiring pneumococcal infections. , 1986, Archives of internal medicine.
[58] J. Bartlett,et al. Bacteriology of hospital-acquired pneumonia. , 1986, Archives of internal medicine.
[59] R. Dixon,et al. Economic costs of respiratory tract infections in the United States. , 1985, The American journal of medicine.
[60] D. Gremillion,et al. Clinical value of paired sputum and transtracheal aspirates in the initial management of pneumonia. , 1985, Chest.
[61] A. Ortqvist,et al. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. , 1985, Scandinavian journal of infectious diseases.
[62] B. Varkey,et al. Empyema thoracis during a ten-year period. Analysis of 72 cases and comparison to a previous study (1952 to 1967). , 1981, Archives of internal medicine.
[63] R. Light,et al. Parapneumonic effusions. , 1980, The American journal of medicine.
[64] R. Tuthill,et al. Differences in etiology of pneumonias in nursing home and community patients. , 1978, JAMA.
[65] D. E. Potts,et al. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. , 1978, Chest.
[66] E. Barrett-Connor. The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. , 2015, The American review of respiratory disease.